Cold email deliverability for startups under 20 people for healthcare and life sciences
How under-20-person startups get cold email deliverability live without hiring — the specific version of the playbook designed for constraint. Written for commercial leaders at healthtech, medtech, and life-sciences companies.
This edition is written for commercial leaders at healthtech, medtech, and life-sciences companies. In healthcare and life sciences, healthcare buyers move under regulatory constraint and reward domain-specific messaging, so the way you install cold email deliverability has to reflect that reality from day one.
The under-20-person version of cold email deliverability is not a diluted enterprise playbook. It is the discipline of landing outbound in the primary inbox, not spam with different constraints: no headcount, no politics, and no time to be wrong for long.
Own it personally as a founder or lean-in operator for the first quarter. Hiring a specialist too early replaces context with process.
Pick one channel, one trigger, one message. Two of anything at this stage is too many and none of them will work.
The binding constraint we see in healthcare and life sciences is almost always regulated-sale cycle length, not intent. Cold email deliverability is only useful in this vertical when it is pointed at that constraint — not at a generic growth number borrowed from another category.
Instrument inbox placement rate across Google and Microsoft in a spreadsheet if you have to. Legibility beats sophistication under 20 people.
The startup-specific trap is sending from your primary domain without warmup or separation, usually because a well-meaning advisor points at what worked at their $50m company. Ignore.
Budget rules: whatever you spend on tools, spend the same on the person operating them. Under-tooling is fine; under-humaning is not.
A working cold email deliverability function at 15 people is a genuine moat — most competitors of that size do not have one, and the discipline carries forward as the company grows.
Concretely for healthcare and life sciences: the healthcare teams that install this get past procurement instead of dying in it. That is the reason it is worth installing cold email deliverability properly rather than half-heartedly across three vendors.
Frequently asked questions
AI Outreach · healthcare — answered
- Does cold email deliverability work for healthcare and life sciences?
- Yes — provided it is aimed at regulated-sale cycle length, not intent rather than a generic growth number. The healthcare teams that install this get past procurement instead of dying in it.
- Can a five-person team run cold email deliverability?
- Yes, if the founder owns it. The lower headcount, the more concentrated the ownership.
- What is the smallest useful cold email deliverability setup?
- One channel, one trigger, one message, and a spreadsheet tracking inbox placement rate across Google and Microsoft.
- Should we hire a specialist for cold email deliverability?
- Not in the first quarter. Own it personally until the model is proven.
- What common advice should startups ignore?
- Anything derived from a company more than 10x larger. Constraints differ.
- What is the healthcare specific pitfall with cold email deliverability?
- Running the generic playbook without adapting to healthcare buyers move under regulatory constraint and reward domain-specific messaging. The install has to be vertical-first.
Growth Broker editorial
Filed under ai outreach · healthcare